Work

Poster: ALL-269 Safety and Pharmacokinetics of Calaspargase Pegol in Adults With Newly Diagnosed Philadelphia-Negative Acute Lymphoblastic Leukemia: A Phase 2/3 Study

Year: 2022

Type: article

Source: Clinical Lymphoma Myeloma & Leukemia

DOI: 10.1016/s2152-2650(22)00734-0

Authors: Wendy Stock, Jae H. Park, Ashkan Emadi, Maher Abdul-Hay, Ryan D. Cassaday, Vinod Pullarkat, Jonathan A. Webster, Susan Pandya, Mark Mogul, Yelena Shvenke, Jian Zhu, Adrien Tessier, Daniel J. DeAngelo

Institutions: University of Chicago, Memorial Sloan Kettering Cancer Center, University of Maryland, Baltimore, University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, NYU Langone’s Laura and Isaac Perlmutter Cancer Center, New York University, University of Washington, Fred Hutch Cancer Center, City Of Hope National Medical Center, City of Hope, Johns Hopkins University, Sidney Kimmel Comprehensive Cancer Center, Institut de Recherches Internationales Servier (France), Dana-Farber Cancer Institute

Language: English

Topic: Acute Lymphoblastic Leukemia research

Subfield: Public Health, Environmental and Occupational Health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4296533248

FWCI:

Cites:

Cited by:

Related to: 10